Blauvelt, A., Strober, B., Langley, R., Burge, D., Pisenti, L., Yassine, M., Kavanagh, S., Arendt, C., Rolleri, R. and Reich, K. 2018. Safety of Certolizumab Pegol in Chronic Plaque Psoriasis: Cumulative Data Over 48 Weeks’ Exposure from Phase 3, Multicenter, Randomized, Placebo-Controlled Studies. SKIN The Journal of Cutaneous Medicine. 2, S1 (Feb. 2018), S16. DOI:https://doi.org/10.25251/skin.2.supp.16.